Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

My patient mix comes in waves—some months it is mostly women with breast cancer struggling with adjuvant endocrine therapy or men in the aftermath of surgery for prostate...
Sometimes, it seems like the easiest way to raise some physician’s hackles is to bring up something that “administration” is doing. Maybe it’s a practice change felt to make things run more smoothly. Maybe it’s a new iteration of the EMR. Maybe it’s data monitoring or asking the physicians to look...
The good kind of problem is having too many choices; the bad kind of problem is having too few choices. Today, I am writing about the ultimate in the good kind of problems: Being an exceptional responder to cancer treatment. I am even trying to enroll in the NCI Exceptional Responders Initiative.
By Don S. Dizon, MD, FACP, and Elaine M. Doroff Significant psychological distress often accompanies the first diagnosis of cancer, but for most patients, I find the distress fades as the cancer gets treated and ultimately becomes a part of their past. Life resumes a new normalcy, interrupted only...
This year’s Community Research Forum Annual Meeting is right around the corner. As Chair of the CRF Council, I am very excited about the Meeting and would like to invite you to participate in this unique opportunity.
As oncologists, we discuss the topic of death or face our patients’ fears of death on a daily basis. But how much time do we reflect these encounters back to ourselves and our own lives?
Looking back on the 1976 Bonadonna study using CMF chemotherapy in women with breast cancer and positive axillary nodes, I consider what went wrong in the search for similarly effective treatment of prostate cancer.
I’m sure I am not alone in saying that I am almost obsessively conscious of time. Namely, that there never seems to be enough of it. As busy oncologists, we all have constant demands on our time, from our leadership, colleagues, drug company reps, insurers, and our families, not to mention the time...
Clinical investigation forms the backbone and the history of medical oncology. Cancer clinical trials provide the evidence we need to demonstrate safety and efficacy before Food and Drug Administration (FDA) approval and evidence for our clinical treatment guidelines. However, it seems to be more...
Radiation oncology residents and medical oncology fellows interface regularly. Understanding each other’s backgrounds helps improve the care of our mutual patients.
The auditorium was designed for around 400 people, but only a quarter of the place was occupied. Some people were sitting next to each other; some were hiding alone at the end of the hall.
Effective communication is vital in all aspects of medicine. In today’s multidisciplinary health care setting, the many members of each patient’s health care team need to work together to deliver optimal care...
I had taken care of her for many years; recommended the adjuvant treatment for her triple-negative breast cancer, then later—walking her through treatment when we found it had recurred in her liver. We had hoped for a long-lasting remission, but then she developed bone and lung metastases.
I am a psychiatrist, but I have never regarded myself as a particularly patient one. In fact, I have become even less patient since I was diagnosed with stage IV gastric adenocarcinoma in 2010 and given a prognosis of less than a year to live. This blog is not meant to reflect the thoughts of a...
Making poster/abstract discussions a major part of the General Sessions will highlight important developments that might have been missed by the meeting participants, and recognize the efforts of those colleagues who work hard to improve the state of the art of palliative cancer care.
As physicians who take care of patients with cancer, all of us worldwide have the same goals of cancer prevention, early detection and screening, improvement in the quality of cancer care, and accelerating research and new therapies. The question is, how can we accomplish these goals in a world...
Dr. Robert Mayer and Dr. Gabriel N. Hortobagyi were named as distinguished members of the OncLive 2015 Giants in Cancer class.
Whenever I prepare for the ASCO Annual Meeting, I always place the sessions I plan to attend into my phone calendar along with all the other meetings that happen that week, such as editorial boards, investigator meetings, and lots of networking coffees.

Pages


Advertisement